Two-Part Antimicrobial Clay Formulation for Stable Bedside Activation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing technologies fail to provide stable, bedside-ready delivery systems for antimicrobial clays that effectively treat pathogen infections, particularly antibiotic-resistant strains like MRSA, and address antibiotic resistance, with conventional clay treatments losing efficacy within 24 hours due to hydration and lack of effective drug delivery systems.
Innovation Solution
A two-part clay delivery system comprising a first part with sterilized clay, suspending agent, and nonionic block EO-PO copolymer, and a second part with pH-neutral water-based EO-PO copolymer, allowing controlled release and activation of clay for enhanced delivery to tissues, ensuring stability and efficacy.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If clay is mixed with water to form a paste for external application, then the clay's antimicrobial activity is activated, but the activity is exhausted within about 24 hours
Solution Approach 1:
The delivery system is divided into two separate parts: a first part containing clay and a second part containing water-based vehicle. The clay remains stable in the first part until application, where it is then released and activated by contact with body fluids, extending the duration of antimicrobial activity beyond the 24-hour limitation of conventional single-paste formulations.
Solution Approach 2:
The clay is pre-formulated in the first part with stabilizing agents and controlled release mechanisms before application. This preliminary preparation allows the clay to maintain its antimicrobial properties without premature activation, enabling extended duration of action once applied to the site of infection.
2Ease of manufacture
If conventional clay paste is applied externally, then the antimicrobial mechanism is simple, but the system lacks stability for extended storage and use
Solution Approach 1:
The system separates the clay component (first part) from the water-based vehicle (second part), allowing each to be optimized for its specific function. The clay remains stable and manufacturable in the first part, while the second part provides controlled activation upon application, achieving both stability and ease of use.
Solution Approach 2:
A controlled-release matrix or carrier system acts as an intermediary between the clay and the water-based vehicle. This intermediary allows the clay to remain stable during storage while enabling controlled release and activation upon application, bridging the gap between manufacturing simplicity and storage stability.
3Speed
If clay is activated by water contact, then the antimicrobial mechanism is rapid, but the release of clay is uncontrolled and leads to rapid exhaustion
Solution Approach 1:
The system provides dynamic control over clay release by incorporating controlled-release mechanisms such as hydrogels, matrices, or pH-responsive carriers. These mechanisms allow rapid activation upon contact with body fluids while controlling the rate of clay release to prevent rapid exhaustion, extending the duration of antimicrobial activity.
Solution Approach 2:
The system utilizes parameter changes in the clay's physical or chemical state to control release. For example, pH-responsive coatings or hydrogels that change their properties in response to body fluid conditions can control the rate of clay release, enabling rapid activation while preventing premature exhaustion of antimicrobial activity.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The system provides long-term stability and accelerated release of antimicrobial clays, effectively treating infections and reducing antibiotic resistance by maintaining clay activity for extended periods, including against antibiotic-resistant bacteria.
Implementation Method 1
accelerated the release of the clay into the water system for activation and delivery that is enhanced by the poloxamers onto a tissue of the body
Implementation Method 2
When clays containing reduced transition metals are contacted with oxygenated water, soluble metals from the minerals likely provide aqueous reactants that drive an antibacterial process
Implementation Method 3
reduced iron becomes oxidized
Implementation Method 4
causing toxicity to bacteria through damaging bacterial membranes... allowing the excess iron to cause intracellular protein damage through oxidation
Implementation Method 5
producing toxic hydroxyl radicals... causing a hydroxyl radical attack on pathogenic intracellular proteins and DNA
Implementation Method 6
a first part comprising clay, glycerin (or other suspending agent), a nonionic block EO-PO copolymer, and optionally a gellant
Implementation Method 7
amphiphilic copolymers... The hydrophobic core of the micelles provides benefits in delivering hydrophobic drugs and other therapeutic agents
Data Source
AI summary
Clay delivery systems for providing antimicrobial compositions are provided. The delivery systems include a two-part active excipient system that delivers clay for various applications of use, including topical applications. The two-part delivery system can include a first part comprising suspending agent(s), poloxamer and optionally a gellant, and a second part that is simultaneously delivered therewith comprising one or more nonionic EO-PO block copolymers in a water-based system. The delivery systems beneficially provide clays in a stable system that also unexpectedly accelerate the release of the clay into the water system for activation and delivery that is enhanced by the poloxamers into the tissue or organ of the body in need of treatment thereof.